Recommended positive controls: 293T.
Predicted reactivity: Mouse (89%), Rat (88%), Dog (93%), Pig (93%), Bovine (91%), Guinea pig (88%).
Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
Prostaglandin inactivation. Contributes to the regulation of events that are under the control of prostaglandin levels. Catalyzes the NAD-dependent dehydrogenation of lipoxin A4 to form 15-oxo-lipoxin A4. Inhibits in vivo proliferation of colon cancer cells.
⚠WARNING: This product can expose you to chemicals including mercury, which is known to the State of California to cause birth defects or other reproductive harm. For more information go to www.P65Warnings.ca.gov.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Protein Aliases: 15-hydroxyprostaglandin dehydrogenase; 15-hydroxyprostaglandin dehydrogenase [NAD(+)]; 15-PGDH; NAD+-dependent 15-hydroxyprostaglandin dehydrogenase; PGDH; Prostaglandin dehydrogenase 1; Short chain dehydrogenase/reductase family 36C member 1; short chain dehydrogenase/reductase family 36C, member 1
Gene Aliases: 15-PGDH; AV026552; HPGD; PGDH; PGDH1; PHOAR1; SDR36C1